Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Praxis Precision Medicines Inc., 3 years.
Praxis Precision Medicines Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 24, 2026 | Praxis Precision Medicines Inc. | Option exercise | +8,566 | $44.25 | $379,046 |
| Jun 24, 2026 | Praxis Precision Medicines Inc. | Option exercise | +3,034 | $147.30 | $446,908 |
| Jun 24, 2026 | Praxis Precision Medicines Inc. | Open-market sale | −10 | $301.44 | $3,014 |
| Jun 24, 2026 | Praxis Precision Medicines Inc. | Open-market sale | −120 | $303.13 | $36,376 |
| Jun 24, 2026 | Praxis Precision Medicines Inc. | Open-market sale | −320 | $305.31 | $97,699 |
| Jun 24, 2026 | Praxis Precision Medicines Inc. | Open-market sale | −683 | $306.77 | $209,524 |
| Jun 24, 2026 | Praxis Precision Medicines Inc. | Open-market sale | −1,240 | $308.24 | $382,218 |
| Jun 24, 2026 | Praxis Precision Medicines Inc. | Open-market sale | −999 | $309.38 | $309,071 |
| Jun 24, 2026 | Praxis Precision Medicines Inc. | Open-market sale | −1,750 | $310.89 | $544,058 |
| Jun 24, 2026 | Praxis Precision Medicines Inc. | Open-market sale | −2,854 | $311.91 | $890,191 |
| Jun 24, 2026 | Praxis Precision Medicines Inc. | Open-market sale | −1,004 | $312.83 | $314,081 |
| Jun 24, 2026 | Praxis Precision Medicines Inc. | Open-market sale | −504 | $313.66 | $158,085 |
| Jun 24, 2026 | Praxis Precision Medicines Inc. | Open-market sale | −1,279 | $314.90 | $402,757 |
| Jun 24, 2026 | Praxis Precision Medicines Inc. | Open-market sale | −837 | $315.71 | $264,249 |
| Jun 10, 2026 | Praxis Precision Medicines Inc. | Grant or award | +1,371 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.